Biocon Biologics & Civica Partner to Expand Insuli...
Category : Approval/Launch 8 March 2025Biocon Biologics and Civica Inc. not-for-profit generic drug and pharmaceutical company founde...
Approval Launch
Lupin Launches Rivaroxaban Tablets USP, 2.5mg in t...
Category : Approval/Launch 8 March 2025Global pharma major Lupin Limited (Lupin) announced that it has launched rivaroxaban tablets USP, 2....
Bioheng Therapeutics Wins Approval for CD7 UCAR-T...
Category : Approval/Launch 7 March 2025Bioheng Therapeutics has received clearance from the U.S. Food and Drug Administration (FDA) for its...
WuXi Biologics Unveils EffiX™ for Advanced Microbi...
Category : Approval/Launch 5 March 2025WuXi Biologics has launched EffiX™, a new microbial expression platform designed to improve th...
EMA Recommends Approval of AbbVie’s Upadacitinib f...
Category : Approval/Launch 4 March 2025AbbVie announced that the European Medicines Agency's Committee for Medicinal Products for Human...
Latest Newsletter Post
-
Zydus Lifesciences Unveils Breakthr..
8 March 2025
-
Lupin Launches Rivaroxaban Tablets..
8 March 2025
-
Biocon Biologics & Civica Partner t..
8 March 2025
-
Bioheng Therapeutics Wins Approval..
7 March 2025
-
FDA & EMA Grant Orphan Drug Status..
7 March 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com